Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
10
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
14
users have liked this narrative
3
users have commented on this narrative
20
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
5
users have commented on this narrative
16
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
BellRing Brands
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Rising Regulatory Burdens And Consumer Skepticism Will Erode Margins
Key Takeaways Rising consumer preference for natural products and sustainability concerns threaten BellRing's core offerings, potentially constraining revenue growth and compressing margins. Heavy brand concentration and growing private label competition could erode market share and pricing power, increasing pressure on profitability and innovation.
View narrative
US$40.00
FV
1.9% overvalued
intrinsic discount
7.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Zoetis
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Regulatory Scrutiny And Trade Barriers Will Limit Market Potential
Key Takeaways Increased regulatory scrutiny, competitive pressures, and sustainability concerns threaten long-term growth, pricing power, and revenue diversity across both companion animal and livestock product lines. Macroeconomic headwinds and structural shifts in protein consumption could compress consumer spending and stall demand for key products, heightening earnings volatility and strategic uncertainty.
View narrative
US$153.00
FV
1.7% overvalued
intrinsic discount
4.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
OPAL Fuels
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Favorable Policies Will Drive RNG Market Expansion
Key Takeaways Supportive regulations and increasing ESG mandates are driving demand for RNG, providing OPAL Fuels with revenue stability and improved margins. Expansion of RNG projects and an integrated business model are positioning OPAL Fuels for sustained earnings growth and reduced reliance on credit pricing.
View narrative
US$3.38
FV
33.3% undervalued
intrinsic discount
18.81%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
6 days ago
author updated this narrative
Cytokinetics
AN
AnalystHighTarget
Consensus Narrative from 19 Analysts
Aging Global Population Will Boost HCM Therapy Uptake
Key Takeaways Positive clinical data and strong commercialization capabilities could enable rapid market expansion and category leadership in difficult-to-treat heart conditions. Growing unmet demand, robust late-stage pipeline, and industry M&A interest make the company well-positioned for strategic partnerships or acquisition.
View narrative
US$112.91
FV
66.5% undervalued
intrinsic discount
119.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Mandatum Oyj
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Digital Transformation And Aging Demographics Will Unfold Upside Despite Risks
Key Takeaways Accelerated margin and profit growth are expected from digital investments and efficiency gains, outpacing current forecasts and enhancing long-term returns. Untapped growth from aging-driven pension markets and international expansion can fuel significant revenue upside and sustained fee-based income growth.
View narrative
€6.94
FV
14.8% undervalued
intrinsic discount
-19.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
High Tide
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Expanding German Medical Cannabis And Cabana Club Will Build Opportunities
Key Takeaways Strategic expansion in the German market and leveraging Canadian connections may boost future revenue. Growth in loyalty programs and data platforms aims to increase customer retention and provide strong high-margin revenue streams.
View narrative
CA$7.33
FV
42.0% undervalued
intrinsic discount
17.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
Hitachi Energy India
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Grid Modernization And HVDC Expansion Will Shape Future Infrastructure
Key Takeaways Strong order backlog and investments in modernization offer sustained revenue growth and expand opportunities from rapid electrification and infrastructure upgrades. Manufacturing expansion, export growth, and high-margin digital solutions are expected to drive margin improvements and earnings resilience.
View narrative
₹19.07k
FV
4.9% overvalued
intrinsic discount
38.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
6 days ago
author updated this narrative
AUO
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Specialized Displays In Automotive And Medical Will Redefine Future Markets
Key Takeaways Strategic focus on specialized, high-value display segments and next-generation technologies drives margin expansion and reduces reliance on volatile, commoditized markets. Global manufacturing optimization and ecosystem expansion through AI integration improve operational flexibility and revenue diversification.
View narrative
NT$13.10
FV
5.3% undervalued
intrinsic discount
2.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
13 days ago
author updated this narrative
Cytokinetics
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
Precision Medicine And Late-stage Trials Will Expand Global Reach
Key Takeaways Successful late-stage clinical trials, commercial readiness, and diversification in products position the company for strong growth and reduced dependence on a single therapy. Strategic capital management and global partnerships support expansion, mitigate risks, and enable significant investment in commercialization and ongoing innovation.
View narrative
US$71.95
FV
47.4% undervalued
intrinsic discount
96.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
10 days ago
author updated this narrative
Value any company in seconds
Popular companies